サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1387372

花粉症市場レポート：2030年までの動向、予測、競合分析

Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

花粉症市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

花粉症の動向と予測

世界の花粉症市場は、2024年から2030年までのCAGRが4.5%で、2030年までに推定72億米ドルに達すると予測されます。この市場の主な促進要因は、アレルギーの発生件数の増加、アレルギーとその管理に対する意識の高まり、そして現在進行中の技術の進歩です。世界の花粉症市場は、食品、吸入、薬剤の各市場におけるビジネスチャンスにより、将来が有望視されています。

花粉症市場の洞察

Lucintel社によると、副腎皮質ステロイド薬はその有効性、安全性、入手のしやすさから、予測期間中も引き続き最大市場です。

この市場の中では、呼吸器系アレルギーの高い成長により、吸入剤が最大のセグメントであり続けるでしょう。

アジア太平洋は、花粉症の有病率の高さと未充足のヘルスケアインフラの存在により、予測期間中最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問について回答する：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の花粉症市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
  • 世界の花粉症市場動向（2018年～2023年）と予測（2024年～2030年）
  • 治療薬クラス別の世界の花粉症市場
    • 抗ヒスタミン薬
    • 鼻詰まり除去剤
    • コルチコステロイド
    • マストセルスタビライザー
    • ロイコトリエン阻害剤
    • 鼻用抗コリン薬
    • 免疫調節剤
    • 自動注射可能なエピネフリン
    • 免疫療法
  • 製品タイプ別の世界の花粉症市場
    • 機器
    • 消耗品
    • サービス
  • アレルゲンタイプ別の世界の花粉症市場
    • 食品
    • 吸入
    • 医薬品
    • その他
  • 最終用途別の世界の花粉症市場
    • 診断研究所
    • 病院
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の花粉症市場
  • 北米の花粉症市場
  • 欧州の花粉症市場
  • アジア太平洋の花粉症市場
  • その他地域の花粉症市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 治療薬クラス別の世界の花粉症市場の成長機会
    • 製品クラス別の世界の花粉症市場の成長機会
    • アレルゲンタイプ別の世界の花粉症市場の成長機会
    • 最終用途別の世界の花粉症市場の成長機会
    • 地域別の世界の花粉症市場の成長機会
  • 世界の花粉症市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の花粉症市場の能力拡大
    • 世界の花粉症市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan
目次

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

A more than 150-page report is developed to help in your business decisions.

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto Injectable Epinephrine
  • Immunotherapy

Pollen Allergy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Pollen Allergy Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug
  • Others

Pollen Allergy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Others

Pollen Allergy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Pollen Allergy Market Insights

Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.

APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
    • 3.3.1: Antihistamines
    • 3.3.2: Decongestants
    • 3.3.3: Corticosteroids
    • 3.3.4: Mast Cell Stabilizers
    • 3.3.5: Leukotriene Inhibitors
    • 3.3.6: Nasal Anticholinergics
    • 3.3.7: Immunomodulators
    • 3.3.8: Auto injectable Epinephrine
    • 3.3.9: Immunotherapy
  • 3.4: Global Pollen Allergy Market by Product Type
    • 3.4.1: Instruments
    • 3.4.2: Consumables
    • 3.4.3: Services
  • 3.5: Global Pollen Allergy Market by Allergen Type
    • 3.5.1: Food
    • 3.5.2: Inhaled
    • 3.5.3: Drug
    • 3.5.4: Others
  • 3.6: Global Pollen Allergy Market by End Use
    • 3.6.1: Diagnostic Laboratories
    • 3.6.2: Hospitals
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pollen Allergy Market by Region
  • 4.2: North American Pollen Allergy Market
    • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.3: European Pollen Allergy Market
    • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.4: APAC Pollen Allergy Market
    • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.5: ROW Pollen Allergy Market
    • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
    • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
    • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
    • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
  • 6.2: Emerging Trends in the Global Pollen Allergy Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ALK-Abello
  • 7.2: Circassia
  • 7.3: DBV Technologies
  • 7.4: Genentech
  • 7.5: GlaxoSmithKline
  • 7.6: HAL Allergy
  • 7.7: Johnson & Johnson
  • 7.8: Meda AB
  • 7.9: Merck & Co
  • 7.10: Mylan